ロイタービデオ

次のビジネス (26 ビデオ)

    ビジネス

    Vaccine-stock valuations are very optimistic: advisor

    Summit Place Financial Advisors' Liz Miller warns investors that the vast majority of coronavirus vaccine compounds that make it to Phase 3 trials ill fail. She tells Reuters' Fred Katayama the valuations of a number of vaccine makers will come down.